More recent studies suggest that the combination of granzyme B and the inflammatory cytokine TNF-α can activate this G2/M checkpoint, potentially reducing the susceptibility of these cancer cells to immune-mediated elimination (137, 158). This evidence concerns the gene GZMB and cancer.